73 related articles for article (PubMed ID: 28153829)
1. Pharmacological inhibition of porcupine induces regression of experimental skin fibrosis by targeting Wnt signalling.
Chen CW; Beyer C; Liu J; Maier C; Li C; Trinh-Minh T; Xu X; Cole SH; Hsieh MH; Ng N; Althage A; Meeusen S; Pan S; Svensson EC; Seidel HM; Schett G; Gergely P; Harris JL; Distler JH
Ann Rheum Dis; 2017 Apr; 76(4):773-778. PubMed ID: 28153829
[TBL] [Abstract][Full Text] [Related]
2. Anti-CX3CL1 (fractalkine) monoclonal antibody attenuates lung and skin fibrosis in sclerodermatous graft-versus-host disease mouse model.
Hasegawa T; Utsunomiya A; Chino T; Kasamatsu H; Shimizu T; Matsushita T; Obara T; Ishii N; Ogasawara H; Ikeda W; Imai T; Oyama N; Hasegawa M
Arthritis Res Ther; 2024 May; 26(1):94. PubMed ID: 38702742
[TBL] [Abstract][Full Text] [Related]
3. Attenuation of fibroblast activation and fibrosis by adropin in systemic sclerosis.
Liang M; Dickel N; Györfi AH; SafakTümerdem B; Li YN; Rigau AR; Liang C; Hong X; Shen L; Matei AE; Trinh-Minh T; Tran-Manh C; Zhou X; Zehender A; Kreuter A; Zou H; Schett G; Kunz M; Distler JHW
Sci Transl Med; 2024 Mar; 16(740):eadd6570. PubMed ID: 38536934
[TBL] [Abstract][Full Text] [Related]
4. Combined inhibition of IL-1, IL-33 and IL-36 signalling by targeting IL1RAP ameliorates skin and lung fibrosis in preclinical models of systemic sclerosis.
Grönberg C; Rattik S; Tran-Manh C; Zhou X; Rius Rigau A; Li YN; Györfi AH; Dickel N; Kunz M; Kreuter A; Matei EA; Zhu H; Skoog P; Liberg D; Distler JH; Trinh-Minh T
Ann Rheum Dis; 2024 Apr; ():. PubMed ID: 38594058
[TBL] [Abstract][Full Text] [Related]
5. Thy-1 plays a pathogenic role and is a potential biomarker for skin fibrosis in scleroderma.
Marangoni RG; Datta P; Paine A; Duemmel S; Nuzzo M; Sherwood L; Varga J; Ritchlin C; Korman BD
JCI Insight; 2022 Oct; 7(19):. PubMed ID: 36066980
[TBL] [Abstract][Full Text] [Related]
6. Cell biology. The unusual case of Porcupine.
Lum L; Clevers H
Science; 2012 Aug; 337(6097):922-3. PubMed ID: 22923569
[TBL] [Abstract][Full Text] [Related]
7. Genetically engineered mouse models to evaluate the role of Wnt secretion in bone development and homeostasis.
Williams BO
Am J Med Genet C Semin Med Genet; 2016 Mar; 172C(1):24-6. PubMed ID: 26818176
[TBL] [Abstract][Full Text] [Related]
8. Wnt pathway inhibition with the porcupine inhibitor LGK974 decreases trabecular bone but not fibrosis in a murine model with fibrotic bone.
Lung H; Wentworth KL; Moody T; Zamarioli A; Ram A; Ganesh G; Kang M; Ho S; Hsiao EC
JBMR Plus; 2024 May; 8(5):ziae011. PubMed ID: 38577521
[TBL] [Abstract][Full Text] [Related]
9. Missing Nuts and Bolts: Translating Pulmonary Fibrosis from Preclinical Murine Models to Human Clinical Trials.
Sundar IK; Matson SM
Lung; 2024 Apr; 202(2):221-222. PubMed ID: 38326503
[No Abstract] [Full Text] [Related]
10. Inhibition of phosphodiesterase 4 (PDE4) reduces dermal fibrosis by interfering with the release of interleukin-6 from M2 macrophages.
Maier C; Ramming A; Bergmann C; Weinkam R; Kittan N; Schett G; Distler JHW; Beyer C
Ann Rheum Dis; 2017 Jun; 76(6):1133-1141. PubMed ID: 28209630
[TBL] [Abstract][Full Text] [Related]
11. Treatment outcome in early diffuse cutaneous systemic sclerosis: the European Scleroderma Observational Study (ESOS).
Herrick AL; Pan X; Peytrignet S; Lunt M; Hesselstrand R; Mouthon L; Silman A; Brown E; Czirják L; Distler JHW; Distler O; Fligelstone K; Gregory WJ; Ochiel R; Vonk M; Ancuţa C; Ong VH; Farge D; Hudson M; Matucci-Cerinic M; Balbir-Gurman A; Midtvedt Ø; Jordan AC; Jobanputra P; Stevens W; Moinzadeh P; Hall FC; Agard C; Anderson ME; Diot E; Madhok R; Akil M; Buch MH; Chung L; Damjanov N; Gunawardena H; Lanyon P; Ahmad Y; Chakravarty K; Jacobsen S; MacGregor AJ; McHugh N; Müller-Ladner U; Riemekasten G; Becker M; Roddy J; Carreira PE; Fauchais AL; Hachulla E; Hamilton J; İnanç M; McLaren JS; van Laar JM; Pathare S; Proudman S; Rudin A; Sahhar J; Coppere B; Serratrice C; Sheeran T; Veale DJ; Grange C; Trad GS; Denton CP
Ann Rheum Dis; 2017 Jul; 76(7):1207-1218. PubMed ID: 28188239
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetic optimitzation of CCG-203971: Novel inhibitors of the Rho/MRTF/SRF transcriptional pathway as potential antifibrotic therapeutics for systemic scleroderma.
Hutchings KM; Lisabeth EM; Rajeswaran W; Wilson MW; Sorenson RJ; Campbell PL; Ruth JH; Amin A; Tsou PS; Leipprandt JR; Olson SR; Wen B; Zhao T; Sun D; Khanna D; Fox DA; Neubig RR; Larsen SD
Bioorg Med Chem Lett; 2017 Apr; 27(8):1744-1749. PubMed ID: 28285914
[TBL] [Abstract][Full Text] [Related]
13. Systems-based analysis of RIG-I-dependent signalling identifies KHSRP as an inhibitor of RIG-I receptor activation.
Soonthornvacharin S; Rodriguez-Frandsen A; Zhou Y; Galvez F; Huffmaster NJ; Tripathi S; Balasubramaniam VR; Inoue A; de Castro E; Moulton H; Stein DA; Sánchez-Aparicio MT; De Jesus PD; Nguyen Q; König R; Krogan NJ; García-Sastre A; Yoh SM; Chanda SK
Nat Microbiol; 2017 Mar; 2():17022. PubMed ID: 28248290
[TBL] [Abstract][Full Text] [Related]
14. Combined ALK and MDM2 inhibition increases antitumor activity and overcomes resistance in human
Wang HQ; Halilovic E; Li X; Liang J; Cao Y; Rakiec DP; Ruddy DA; Jeay S; Wuerthner JU; Timple N; Kasibhatla S; Li N; Williams JA; Sellers WR; Huang A; Li F
Elife; 2017 Apr; 6():. PubMed ID: 28425916
[TBL] [Abstract][Full Text] [Related]
15. Progressive fibrosing interstitial lung disease associated with systemic autoimmune diseases.
Fischer A; Distler J
Clin Rheumatol; 2019 Oct; 38(10):2673-2681. PubMed ID: 31423560
[TBL] [Abstract][Full Text] [Related]
16. Potential of nintedanib in treatment of progressive fibrosing interstitial lung diseases.
Wollin L; Distler JHW; Redente EF; Riches DWH; Stowasser S; Schlenker-Herceg R; Maher TM; Kolb M
Eur Respir J; 2019 Sep; 54(3):. PubMed ID: 31285305
[TBL] [Abstract][Full Text] [Related]
17.
Baarsma HA; Königshoff M
Thorax; 2017 Aug; 72(8):746-759. PubMed ID: 28416592
[TBL] [Abstract][Full Text] [Related]
18. Noncanonical WNT5A controls the activation of latent TGF-β to drive fibroblast activation and tissue fibrosis.
Trinh-Minh T; Chen CW; Tran Manh C; Li YN; Zhu H; Zhou X; Chakraborty D; Zhang Y; Rauber S; Dees C; Lin NY; Kah D; Gerum R; Bergmann C; Kreuter A; Reuter C; Groeber-Becker F; Eckes B; Distler O; Fabry B; Ramming A; Schambony A; Schett G; Distler JH
J Clin Invest; 2024 Mar; 134(10):. PubMed ID: 38747285
[TBL] [Abstract][Full Text] [Related]
19. The role of Evi/Wntless in exporting Wnt proteins.
Wolf L; Boutros M
Development; 2023 Feb; 150(3):. PubMed ID: 36763105
[TBL] [Abstract][Full Text] [Related]
20. A broad look into the future of systemic sclerosis.
Riemekasten G; Distler JHW
Ther Adv Musculoskelet Dis; 2022; 14():1759720X221109404. PubMed ID: 35966183
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
